drugset / Trial / NCT02099916
Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVF
RandomizedParallel-groupSingle-blindTreatment
Summary
Poor responders to ovarian stimulation represents one of the most frustrating problems in reproductive medicine. The investigators hypothesize that ovarian response of those patients could improve by treating these patients with 25 mg DHEA tid for 12 weeks prior to stimulation.
Timeline
- Start
- 2014-10
- Primary completion
- 2014-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | DHEA | Unknown | 25 mg | Oral |
| Comparator | Gonal | Unknown | — | — |
| Comparator | Menopur | Protein / enzyme biologic | — | — |